Condition: Takayasu Arteritis · Sponsor: Shanghai Zhongshan Hospital
The aim of this study is to evaluate and compare the efficacy and safety of tofacitinib and methotrexate based on prednisone therapy in patients with Takayasu arteritis
This description comes directly from the study's public registry record.
Lindi Jiang, Ph.D., M.D. · 021-64041990 · zsh-rheum@hotmail.com
Xiufang Kong, Ph.D., M.D. · 021-64041990 · kongxiufang2007@163.com
Always discuss trial participation with your own doctor first.
| Lindi Jiang | Shanghai, Shanghai Municipality, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05102448